Podcast: Vaxxinity CEO On Lecanemab Challenger, Migraine Buster And Lipid-Lowering Vaccine

COVID-19 Vaccine Superior To mRNA Vaccines?

Among Vaxxinity’s immunotherapeutic vaccine candidates are one for Alzheimer’s that shows a 50% reduction in cognitive decline, another that shows superior durability than Pfizer and Moderna’s COVID-19 vaccines and one that could prevent migraines. Vaxxinity CEO speaks to Scrip about these and more in this interview

Scrip Podcast Special
An Audio Interview With Vaxxinity's CEO Mei Mei Hu

More from R&D

More from Scrip